At a glance
ClinicalIndex Comparison RecordN/ACompleted· 490 enrolled
Drug / intervention
heart team meeting and discussionbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Feasibility and Effectiveness of a Real-time Heart Team Approach in Complex Coronary Artery Disease
China National Center for Cardiovascular Diseases·interventional·Posted Aug 24, 2022·Updated Jul 30, 2025
In Brief
A clinical study evaluating heart team meeting and discussion for Cardiovascular Diseases and 2 related conditions. Completed, enrolled 490 participants across 1 site.
Detailed Summary
This study is aimed to evaluate the clinical outcomes, efficiency and feasibility of the real-time heart team approach and the conventional heart team approach.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedAug 2022
Enrollment StartSep 2023
Primary CompletionMay 2025
Study CompletionJun 2025
TodayJul 2026
First PostedAug 24, 2022
Enrollment StartSep 15, 2023
Primary CompletionMay 21, 2025
Study CompletionJun 11, 2025
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 3.9 years ago
Interventions
heart team meeting and discussionbehavioral
When the patient is eligible for the study, the interventional cardiologist will invite a cardiac surgeon to conduct a heart team discussion. Both specialists will assess the patient comprehensively and make an optimal decision for the patient, with consideration patient's preference.